--- a
+++ b/clusters/9knumclustersv2/clust_1340.txt
@@ -0,0 +1,53 @@
+PHASE IB: Transaminases (AST and/or ALT) =< . x ULN
+Transaminases =< . x ULN, except in known hepatic disease, wherein may be =<  x ULN
+ARM I&II: Transaminases =< times above the upper limits of the institutional normal
+Transaminases <  x normal at the time of transplant.
+Research participant serum total bilirubin or transaminases does not exceed  x normal limit
+Transaminases <  x normal at the time of transplant
+Transaminases =<  times above the upper limits of the institutional normal
+Transaminases =<  x upper limit of normal (ULN) or if liver metastases were present, =<  x ULN
+Transaminases (serum glutamate pyruvatetransaminase [SGPT]) =< . x upper limit of normal (ULN)
+Serum total bilirubin > . and/or serum transaminases >  X the upper limits of normal
+Documented bilirubin and hepatic transaminases of =< . x upper limit of normal (ULN)
+Serum transaminases =<  x ULN
+PART : Transaminases must be <  x the upper limit of normal
+Research participant transaminases does not exceed  x normal limit
+Transaminases > x upper limit of normal for age
+The patient has a history of liver disease (excluding Gilberts disease and non-active hepatitis C) and/or elevation of transaminases or bilirubin above the normal limit
+Transaminases less than or equal  x upper limit of normal unless related to the disease
+Liver: transaminases <  x upper limit of normal and bilirubin <  x upper limit of normal
+Bilirubin < . x ULN; transaminases <  x ULN
+Serum transaminases =< X ULN.\r\n* Note: Transaminases can be up to  X ULN in the setting of liver metastases.
+Transaminases must be <  x the upper limit of normal per reference values of treating institution
+Patients must have serum direct bilirubin =< . mg/dl and transaminases =< x institution upper limit of normal
+Transaminases < . x upper limit of normal
+Transaminases < . x upper limit of normal (ULN)
+Transaminases < . x upper limit of normal (up to  x upper limit of normal [ULN] in patients with liver metastases)
+Transaminases < x upper limit of normal
+Liver transaminases within . times ULN
+Liver transaminases > -times the upper limit of normal
+Serum transaminases activity =< . x ULN, with the exception of serum transaminases (<  x ULN) if the patient has liver metastases
+Transaminases <  x ULN
+Hepatic dysfunction as evidenced by elevated transaminases
+Transaminases must be <  x the upper limit of normal per reference values of referring institution
+Transaminases <  times the upper limit of normal
+Transaminases =<  x the upper limit of normal for age appropriate indices
+Serum transaminases activity =<  x ULN
+Subject with liver failure as defined by a serum total bilirubin > . and/or serum transaminases >  x the upper limits of normal
+DONOR: Hepatic transaminases =< . x ULN
+Transaminases >  times upper normal limit
+Transaminases =<  x ULN, except in known hepatic disease, wherein may be =<  x ULN
+Transaminases =<  x ULN
+Active liver disease with elevated transaminases >  x ULN
+Hepatic dysfunction (elevated transaminases or bilirubin >  times normal), drawn within  days of consent
+Documented liver disease with marked elevation of transaminases > x ULN or,
+Unexplained persistent elevation of transaminases (>  times upper limits of normal)
+History of, or current, active or chronic liver disease even if transaminases have normalized
+Transaminases =< . x institutional upper limit of normal (IULN)
+Transaminases =< . x institutional upper limit of normal (IULN)
+SUB-STUDY I: Liver transaminases >  times the upper limit of normal
+SUB-STUDY II: Liver transaminases >  times the upper limit of normal
+SUB-STUDY III: Liver transaminases >  times the upper limit of normal
+Liver transaminases >  times the upper limit of normal
+Transaminases =< IULN
+Elevated LDH levels are permissible if transaminases are =< IULN